A day after announcing a business split-off to focus on weight loss and diabetes...
Emergent has entered a strategic financial investment agreement with Swiss Rocke...
The EMA warns of products being sold as dendritic cell therapies with little evi...
Vori Health has secured $53m in a Series B funding round, supporting its value-b...
The two companies will work together on Zealand’s amylin analogue petrelintide a...
Entos Pharmaceuticals has announced an investment of C$62m ($43.05m) from the go...
WuXi XDC Cayman has signed a memorandum of understanding (MoU) with South Korea-...
The deal comes after a challenging few years for 2seventy bio, which had diveste...
The multi-year manufacturing deal with CordenPharma will secure future supply of...
Atsena Therapeutics has received fast track designation from the FDA for ATSN-20...
Europe’s drug regulatory agency has given Kizfizo a negative opinion for the sec...
Ono Pharmaceuticals has secured the global rights to sapablursen, an RNA-targeti...
The specialist in temperature-sensitive pharmaceutical shipments, is introducing...
Roche has announced the launch of the Roche Genentech Innovation Center Boston, ...
The offer represents a 3.6% increase from the initial offer in January 2025, fro...
The EC has approved BMS Opdivo in combination with Yervoy as a first-line treatm...
